In a landscape where the financial health of many hospitals is ailing, a prudent examination of operational costs is not just smart management—it’s an imperative. A recent report by Kaufman Hall revealed a modest uptick in hospital margins in the US, from 0.9% in July to 1.1% in August, hinting at a gradual, albeit nonlinear, recovery from the financial bruise left by the pandemic.
However, as the case of Heywood Healthcare in the US demonstrates, many institutions are still on shaky ground, grappling with workforce shortages, supply chain disruptions, and low reimbursement rates among other hurdles. Amid these challenges, the call for investments in affordable care rings loud but falls on the strapped purses of hospitals.
An analysis by accounting firm BDO paints a stark picture in countries like the Netherlands as well: with dwindling revenues and razor-thin margins, hospitals are in a tight spot, struggling to fund necessary advancements that could streamline operations and enhance patient care.
One avenue that has been somewhat overlooked in the discourse around hospital expenditure is the significant cost tied to consumables. These seemingly minor expenses accumulate over time, draining resources that could be channeled towards more impactful investments. A quintessential example is the use of disposable caps for thermometers to avert cross-contamination—a practice that, while hygienic, is an avoidable expense. The solution lies in embracing alternatives like Exergen’s Temporal Artery Thermometers, which offer a blend of accuracy, ease of use, and the much-needed feature of reusability. These thermometers can be sanitized with cotton cloths and medicinal alcohol, eliminating the need for disposable caps, saving hospitals considerable amounts of money annually.
The shift towards such cost-effective alternatives is not about pinching pennies but about reallocating resources judiciously. As hospitals navigate through the financial aftermath of the pandemic, every dollar saved on avoidable expenses is a dollar available for essential investments. It’s about trimming the fat to allow more nourishment to reach the core: improved patient care, upgraded infrastructure, and the adoption of modern healthcare technologies.
The road to financial recovery and enhanced patient care is laden with challenges, but with a meticulous review of operational costs and a collaborative approach towards funding, hospitals can traverse this rocky terrain. Steering clear of avoidable costs, like consumables, and channeling funds towards pivotal investments is not just a blueprint for financial stability—it’s a pledge towards a healthier society.
EXERGEN P/N 850163, Rev 1